Amgen Inc vs. Ginkgo Bioworks Holdings, Inc.
Amgen Inc (AMGN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AMGN | DNA | |
|---|---|---|
| Market Cap | $237.36 billion | $539.34 million |
AMGN leads on 1 of 1 size & scale factors.
Dividend
| AMGN | DNA | |
|---|---|---|
| Dividend Yield | 2.28% | — |
AMGN and DNA split the dividend factors evenly.
Risk & Sentiment
| AMGN | DNA | |
|---|---|---|
| Short Interest | 1.66% | 19.24% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, DNA overview, DNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
